RAFAEL HOLDINGS, INC. Increase (Decrease) in Interest and Dividends Receivable
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Interest and Dividends Receivable of $212.00 thousand for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. increase (decrease) in interest and dividends receivable for the quarter ending 2023-04-30 was $38.00K.
| Period end | Increase (Decrease) in Interest and Dividends Receivable 3 month | Increase (Decrease) in Interest and Dividends Receivable 6 month | Increase (Decrease) in Interest and Dividends Receivable 9 month |
|---|---|---|---|
| 2023-04-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $212.00K 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $174.00K 10-Q · filed 2023-03-14 | ||
| 2022-04-30 | $258.00K 10-Q · filed 2023-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |